Novo Nordisk SWOT Analysis, Competitors & USP
SWOT analysis of Novo Nordisk analyses the brand by its strengths, weaknesses, opportunities & threats. In Novo Nordisk SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.
SWOT Analysis is a proven management framework which enables a brand like Novo Nordisk to benchmark its business & performance as compared to the competitors. Novo Nordisk is one of the leading brands in the pharma and healthcare sector.
The table below lists the Novo Nordisk SWOT (Strengths, Weaknesses, Opportunities, Threats), top Novo Nordisk competitors and includes its target market, segmentation, positioning & Unique Selling Proposition (USP).
In this article:
| Novo Nordisk Brand Analysis | |
|---|---|
| Parent Company |
Novo Nordisk |
| Category |
Pharmaceutical |
| Sector | |
| Tagline/ Slogan |
Changing diabetes |
| USP |
It is leading healthcare company with experience in diabetes treatment & considerable experience in other area also |
| Novo Nordisk STP | |
| Segment |
Diabetes, homeostasis management & hormone replacement therapy |
| Target Group |
Endocrinologists, healthcare professionals providing treatment to patients suffering from diabetes & other hormonal disorders |
| Positioning |
Novo Nordisk is leading healthcare company with more than 89 years of experience in diabetes treatment. |
| SWOT Analysis of Novo Nordisk | |
| Novo Nordisk Strengths |
Below are the Strengths in the SWOT Analysis of Novo Nordisk: 1. Deep knowledge about diabetes & experience in its treatment 2. Free cash flow can be used for expansion, acquisition or R&D 3. Around 33,000 well trained employees in 75 countries 4. Wide global footprint (present in 190 countries) 5. great diversity in senior management teams which is requisite for growth |
| Novo Nordisk Weaknesses |
Here are the weaknesses in the Novo Nordisk SWOT Analysis: 1. Company suffered negative brand image due to its failure to provide information about side effects of Victoza. 2. Past legal actions have created negative image for company |
| Novo Nordisk Opportunities |
Following are the Opportunities in Novo Nordisk SWOT Analysis: 1. Increasing prevalence of diabetes & other chronic ailments due to increasing urbanization & average life expectancy 2. Biosimiler market has strong growth opportunities 3. Growing numbers of health conscious people |
| Novo Nordisk Threats |
The threats in the SWOT Analysis of Novo Nordisk are as mentioned: 1. Increasing public debt in European countries 2. Negative consequences of healthcare reforms in major markets 3. Stringent healthcare regulations 4. Increasing pressure in public spending on healthcare due to economic slowdown |
| Novo Nordisk Competition | |
| Novo Nordisk Competitors |
Below are the top 4 competitors of Novo Nordisk: 1. Eli Lilly 3. Biocon |
This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.
Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Novo Nordisk. This section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2500 brands from over 20 industry sectors.
Continue Reading:
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute
